On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors.

Mariangela Pucci, Elizabeta Zaplatic, Maria Vittoria Micioni Di Bonaventura, Emanuela Micioni Di Bonaventura, Paolo De Cristofaro, Mauro Maccarrone, Carlo Cifani, Claudio D'Addario
Author Information
  1. Mariangela Pucci: Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo TE, Italy. ORCID
  2. Elizabeta Zaplatic: Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo TE, Italy.
  3. Maria Vittoria Micioni Di Bonaventura: Pharmacology Unit, School of Pharmacy, University of Camerino, 62032 Camerino MC, Italy. ORCID
  4. Emanuela Micioni Di Bonaventura: Pharmacology Unit, School of Pharmacy, University of Camerino, 62032 Camerino MC, Italy. ORCID
  5. Paolo De Cristofaro: Clinical Endocrinology and Metabolism Outpatient Clinic, 64021 Giulianova TE, Italy.
  6. Mauro Maccarrone: Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila AQ, Italy. ORCID
  7. Carlo Cifani: Pharmacology Unit, School of Pharmacy, University of Camerino, 62032 Camerino MC, Italy. ORCID
  8. Claudio D'Addario: Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo TE, Italy.

Abstract

Different neuromodulatory systems are involved in long-term energy balance and body weight and, among these, evidence shows that the endocannabinoid system, in particular the activation of type-1 cannabinoid receptor, plays a key role. We here review current literature focusing on the role of the gene encoding type-1 cannabinoid receptors in the CNS and on the modulation of its expression by food intake and specific eating behaviors. We point out the importance to further investigate how environmental cues might have a role in the development of obesity as well as eating disorders through the transcriptional regulation of this gene in order to prevent or to treat these pathologies.

Keywords

References

  1. Pharmacol Ther. 2005 May;106(2):133-45 [PMID: 15866316]
  2. Front Neurosci. 2018 Apr 24;12:271 [PMID: 29740277]
  3. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3201-15 [PMID: 23108540]
  4. Cell. 2012 Mar 2;148(5):1039-50 [PMID: 22385967]
  5. Pharmacol Ther. 2002 Aug;95(2):185-90 [PMID: 12182965]
  6. Front Behav Neurosci. 2016 Dec 27;10:241 [PMID: 28082878]
  7. J Clin Invest. 2015 Mar 2;125(3):891-8 [PMID: 25642767]
  8. Front Neurosci. 2018 Feb 02;12:40 [PMID: 29456490]
  9. J Physiol Biochem. 2016 Jun;72(2):183-99 [PMID: 26880264]
  10. Drug Alcohol Depend. 2009 Sep 1;104(1-2):11-6 [PMID: 19443135]
  11. Brain Res. 2003 Sep 5;983(1-2):144-51 [PMID: 12914975]
  12. Trends Cogn Sci. 2011 Jan;15(1):37-46 [PMID: 21109477]
  13. J Endocrinol Invest. 2003 Oct;26(10):1041-4 [PMID: 14759080]
  14. Genes Brain Behav. 2009 Oct;8(7):728-32 [PMID: 19659925]
  15. Mol Psychiatry. 2004 Oct;9(10):916-31 [PMID: 15289816]
  16. Compr Physiol. 2016 Dec 6;7(1):1-15 [PMID: 28134998]
  17. Trends Pharmacol Sci. 2015 May;36(5):277-96 [PMID: 25796370]
  18. Endocrinology. 2012 Sep;153(9):4136-43 [PMID: 22778221]
  19. FEBS Lett. 2005 Jan 3;579(1):259-64 [PMID: 15620723]
  20. J Obes. 2011;2011:432607 [PMID: 21773005]
  21. Cell Metab. 2010 Apr 7;11(4):273-85 [PMID: 20374960]
  22. Nat Neurosci. 2012 Oct;15(10):1343-9 [PMID: 23007189]
  23. Peptides. 2000 Nov;21(11):1735-42 [PMID: 11090929]
  24. Neuroscience. 1998 Mar;83(2):393-411 [PMID: 9460749]
  25. J Pharm Biomed Anal. 2018 Oct 25;160:119-125 [PMID: 30077950]
  26. Clin Epigenetics. 2015 Jul 11;7:66 [PMID: 27408648]
  27. Adv Genomics Genet. 2015;5:131-150 [PMID: 27013903]
  28. Pharmacol Rev. 2011 Sep;63(3):461-70 [PMID: 21752875]
  29. Neurosci Biobehav Rev. 2014 Nov;47:203-24 [PMID: 25173635]
  30. Physiol Behav. 2008 Apr 22;94(1):121-35 [PMID: 18164737]
  31. Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):126-30 [PMID: 14755457]
  32. Adv Clin Exp Med. 2017 Jan-Feb;26(1):143-148 [PMID: 28397446]
  33. Obes Rev. 2013 Jan;14(1):2-18 [PMID: 23016694]
  34. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6 [PMID: 2308954]
  35. Psychoneuroendocrinology. 2019 May;103:306-315 [PMID: 30776574]
  36. Trends Neurosci. 2013 Feb;36(2):65-73 [PMID: 23318157]
  37. Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H992-1000 [PMID: 14615281]
  38. J Physiol. 2009 Nov 15;587(Pt 22):5305-14 [PMID: 19770186]
  39. Endocrine. 2017 Mar;55(3):839-852 [PMID: 27858284]
  40. PLoS One. 2015 Oct 07;10(10):e0139632 [PMID: 26445370]
  41. Nat Neurosci. 2014 Feb;17(2):248-53 [PMID: 24441680]
  42. Cell Metab. 2018 Jan 9;27(1):42-56 [PMID: 29107504]
  43. Gene. 2012 Mar 10;495(2):194-8 [PMID: 22244745]
  44. Eur Rev Med Pharmacol Sci. 2010 Mar;14(3):197-201 [PMID: 20391958]
  45. Sci Rep. 2016 Sep 19;6:33302 [PMID: 27641999]
  46. Neuropsychopharmacology. 2015 Nov;40(12):2788-800 [PMID: 25944409]
  47. Addict Biol. 2016 Nov;21(6):1168-1185 [PMID: 26387568]
  48. Nat Neurosci. 2005 May;8(5):585-9 [PMID: 15856067]
  49. Br J Pharmacol. 2007 Dec;152(7):1092-101 [PMID: 17876302]
  50. Dis Model Mech. 2017 Jun 1;10(6):679-689 [PMID: 28592656]
  51. J Nutr. 2009 Mar;139(3):629-32 [PMID: 19176746]
  52. Memory. 2017 Mar;25(3):335-343 [PMID: 27108777]
  53. Br J Pharmacol. 2017 Aug;174(16):2682-2695 [PMID: 28561272]
  54. Neuroscience. 1997 Mar;77(2):299-318 [PMID: 9472392]
  55. Glia. 2010 Jul;58(9):1017-30 [PMID: 20468046]
  56. Methods Mol Biol. 2012;829:377-93 [PMID: 22231828]
  57. PLoS One. 2008 Mar 12;3(3):e1797 [PMID: 18335063]
  58. Nutr Res Rev. 2014 Jun;27(1):172-85 [PMID: 24933167]
  59. Proc Nutr Soc. 2012 Nov;71(4):478-87 [PMID: 22800810]
  60. Cell Metab. 2011 Jan 5;13(1):105-13 [PMID: 21195353]
  61. Annu Rev Nutr. 2010 Aug 21;30:423-40 [PMID: 20645854]
  62. J Mol Neurosci. 2015 Feb;55(2):480-91 [PMID: 25001005]
  63. Ann N Y Acad Sci. 2009 Apr;1163:504-7 [PMID: 19456400]
  64. Int J Obes Relat Metab Disord. 2004 Apr;28(4):640-8 [PMID: 14770190]
  65. Mol Psychiatry. 2019 Jun;24(6):901-915 [PMID: 30353170]
  66. Nat Rev Neurosci. 2015 Jan;16(1):30-42 [PMID: 25524120]
  67. Psychoneuroendocrinology. 2009 May;34(4):620-4 [PMID: 19046818]
  68. Neuropharmacology. 2009;56 Suppl 1:3-8 [PMID: 18617195]
  69. J Clin Endocrinol Metab. 2007 Jun;92(6):2382-6 [PMID: 17405839]
  70. Mol Neurobiol. 2017 Dec;54(10):8332-8347 [PMID: 27924524]
  71. Int J Cancer. 2008 Sep 1;123(5):1025-33 [PMID: 18546271]
  72. Int J Obes Relat Metab Disord. 2001 May;25 Suppl 1:S51-5 [PMID: 11466589]
  73. J Neurosci. 2005 Sep 7;25(36):8295-302 [PMID: 16148237]
  74. Nat Commun. 2020 Feb 7;11(1):782 [PMID: 32034128]
  75. Gynecol Endocrinol. 2011 Dec;27(12):1023-7 [PMID: 21480765]
  76. Front Neurosci. 2015 Jun 08;9:187 [PMID: 26106286]
  77. Neurosci Lett. 2007 Jun 4;419(3):231-5 [PMID: 17462824]
  78. Int J Mol Sci. 2019 Nov 22;20(23): [PMID: 31771126]
  79. Eur J Pharmacol. 2003 Feb 7;461(1):27-34 [PMID: 12568912]
  80. Endocrinol Metab Clin North Am. 2014 Mar;43(1):75-102 [PMID: 24582093]
  81. Transl Psychiatry. 2016 Jul 12;6(7):e853 [PMID: 27404285]
  82. Behav Brain Res. 2010 May 1;209(1):1-12 [PMID: 20035790]
  83. J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):114-120 [PMID: 27002803]
  84. Trends Endocrinol Metab. 2015 Oct;26(10):524-537 [PMID: 26412154]
  85. Semin Immunol. 2014 Oct;26(5):380-8 [PMID: 24882055]
  86. J Neurosci. 2008 Sep 24;28(39):9702-9 [PMID: 18815256]
  87. Biochimie. 2006 Dec;88(12):1889-97 [PMID: 16949718]
  88. Drug Alcohol Depend. 2002 Feb 1;65(3):221-4 [PMID: 11841893]
  89. Nat Neurosci. 2016 Dec;19(12):1628-1635 [PMID: 27643429]
  90. J Clin Invest. 2017 Nov 1;127(11):4148-4162 [PMID: 29035280]
  91. Ann Nutr Metab. 2018;73(1):76-85 [PMID: 30016776]
  92. J Neuroendocrinol. 2008 Jun;20(6):850-7 [PMID: 18601709]
  93. Dis Markers. 2008;25(1):67-74 [PMID: 18776593]
  94. Arch Gen Psychiatry. 2012 Jul;69(7):732-40 [PMID: 22393204]
  95. J Vis Exp. 2015 Oct 22;(105):e52927 [PMID: 26555618]
  96. Eur J Biochem. 2004 Dec;271(23-24):4909-20 [PMID: 15606779]
  97. J Biol Chem. 1996 Mar 22;271(12):6941-6 [PMID: 8636122]
  98. Pharmacogenomics. 2008 Nov;9(11):1647-56 [PMID: 19018721]
  99. J Nutrigenet Nutrigenomics. 2012;5(6):305-13 [PMID: 23207972]
  100. Obes Rev. 2010 Mar;11(3):185-201 [PMID: 19845870]
  101. Psychopharmacology (Berl). 1999 Apr;143(3):315-7 [PMID: 10353436]
  102. J Biol Chem. 1995 Feb 24;270(8):3726-31 [PMID: 7876112]
  103. J Clin Invest. 2003 Aug;112(3):423-31 [PMID: 12897210]
  104. JAMA. 2006 Feb 15;295(7):761-75 [PMID: 16478899]
  105. Mol Cell Probes. 1999 Aug;13(4):321-3 [PMID: 10441206]
  106. Neuropharmacology. 2017 Sep 15;124:38-51 [PMID: 28579186]
  107. Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):736-40 [PMID: 19016476]
  108. Trends Neurosci. 2013 Feb;36(2):101-9 [PMID: 23333343]
  109. Int J Obes (Lond). 2007 Jun;31(6):908-12 [PMID: 17160086]
  110. Front Genet. 2019 Jun 14;10:523 [PMID: 31258545]
  111. Pharmacol Biochem Behav. 1995 Aug;51(4):731-7 [PMID: 7675852]
  112. Physiol Behav. 2011 Jul 25;104(1):149-56 [PMID: 21557958]
  113. Alcohol Clin Exp Res. 2012 Feb;36(2):267-71 [PMID: 22085192]
  114. Cell. 2007 Apr 20;129(2):251-62 [PMID: 17448988]
  115. Eur J Pharmacol. 2001 May 11;419(2-3):207-14 [PMID: 11426843]
  116. J Leukoc Biol. 2003 Oct;74(4):486-96 [PMID: 12960289]
  117. J Neural Transm (Vienna). 2007;114(8):1055-63 [PMID: 17370106]
  118. Biol Psychiatry. 2011 Oct 15;70(8):777-84 [PMID: 21718968]
  119. Handb Exp Pharmacol. 2005;(168):299-325 [PMID: 16596779]
  120. J Neuroendocrinol. 2008 Nov;20(11):1288-94 [PMID: 18752650]
  121. Brain Res. 2002 Oct 18;952(2):232-8 [PMID: 12376184]
  122. Medicine (Baltimore). 2019 Nov;98(46):e17403 [PMID: 31725603]
  123. Front Neurosci. 2019 Feb 05;13:59 [PMID: 30804742]
  124. Nature. 2001 Apr 12;410(6830):822-5 [PMID: 11298451]
  125. J Physiol. 2004 Sep 15;559(Pt 3):923-38 [PMID: 15272041]
  126. Pharmacogenomics J. 2010 Jun;10(3):232-42 [PMID: 20010914]
  127. Int J Eat Disord. 2019 Nov;52(11):1251-1262 [PMID: 31456239]
  128. J Psychopharmacol. 2019 Dec;33(12):1550-1561 [PMID: 31161847]
  129. Metabolism. 2014 Sep;63(9):1198-208 [PMID: 24997500]
  130. Alcohol Clin Exp Res. 2016 Mar;40(3):467-73 [PMID: 26857901]
  131. Curr Top Behav Neurosci. 2009;1:347-71 [PMID: 21104391]
  132. Child Adolesc Psychiatry Ment Health. 2008 Nov 17;2(1):33 [PMID: 19014633]
  133. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):308-21 [PMID: 24006151]
  134. Cell Metab. 2013 Apr 2;17(4):475-90 [PMID: 23562074]
  135. FASEB J. 2005 Sep;19(11):1567-9 [PMID: 16009704]
  136. Endocrine. 2007 Apr;31(2):138-41 [PMID: 17873324]
  137. Nutrients. 2018 Jan 11;10(1): [PMID: 29324652]
  138. Int J Eat Disord. 2020 May;53(5):432-446 [PMID: 32275093]
  139. Adv Exp Med Biol. 2001;493:229-33 [PMID: 11727770]
  140. Front Pharmacol. 2020 Feb 04;10:1669 [PMID: 32116676]
  141. Eur J Neurosci. 1999 Dec;11(12):4213-25 [PMID: 10594647]
  142. Eur J Endocrinol. 2010 Sep;163(3):407-12 [PMID: 20587580]
  143. Diabetes Metab Res Rev. 2011 Jul;27(5):506-11 [PMID: 21472841]
  144. Nat Commun. 2013;4:1973 [PMID: 23748922]
  145. Eur Neuropsychopharmacol. 2008 Oct;18(10):751-9 [PMID: 18579347]
  146. Prog Brain Res. 2006;153:57-73 [PMID: 16876568]
  147. Psychiatr Clin North Am. 2019 Mar;42(1):33-43 [PMID: 30704638]
  148. Br J Pharmacol. 2002 Jun;136(4):550-7 [PMID: 12055133]
  149. Arch Biochem Biophys. 2001 Sep 15;393(2):321-8 [PMID: 11556820]
  150. J Neuroendocrinol. 2008 May;20 Suppl 1:110-5 [PMID: 18426509]
  151. Braz J Med Biol Res. 2017 May 04;50(6):e6141 [PMID: 28492810]
  152. J Neurochem. 2017 Aug;142(4):521-533 [PMID: 28608535]
  153. J Biol Chem. 2010 Jun 18;285(25):19002-11 [PMID: 20410309]
  154. Pharmacogenomics. 2010 May;11(5):693-702 [PMID: 20415562]
  155. Nature. 1990 Aug 9;346(6284):561-4 [PMID: 2165569]
  156. J Endocrinol. 2014 Jan 08;220(2):T25-46 [PMID: 24222039]
  157. Mol Psychiatry. 2000 Mar;5(2):128-30 [PMID: 10822338]
  158. Exp Biol Med (Maywood). 2005 Apr;230(4):225-34 [PMID: 15792943]
  159. Int J Eat Disord. 2019 Jan;52(1):51-60 [PMID: 30578649]

Grants

  1. 713714/Marie Skłodowska-Curie grant agreement no. 713714 (Rep-Eat - H2020-MSCACOFUND-2015

MeSH Term

Animals
Feeding Behavior
Gene Expression Regulation
Humans
Mice
Promoter Regions, Genetic
Rats
Receptor, Cannabinoid, CB1
Transcription, Genetic

Chemicals

CNR1 protein, human
CNR1 protein, mouse
Cnr1 protein, rat
Receptor, Cannabinoid, CB1

Word Cloud

Created with Highcharts 10.0.0type-1cannabinoidrolegeneeatingreceptorfoodintakebehaviorstranscriptionalregulationDifferentneuromodulatorysystemsinvolvedlong-termenergybalancebodyweightamongevidenceshowsendocannabinoidsystemparticularactivationplayskeyreviewcurrentliteraturefocusingencodingreceptorsCNSmodulationexpressionspecificpointimportanceinvestigateenvironmentalcuesmightdevelopmentobesitywelldisordersorderpreventtreatpathologiesRoleCentralType-1CannabinoidReceptorGeneRegulationFoodIntakeEatingBehaviors

Similar Articles

Cited By